Comparison of tissue culture and animal models for assessment of Cryptospridium parvum infection

Experimental Parasitology

Volumn 101, Issue 2-3, 2002, Pages 97-106

  Slifko, Theresa R ^a   Huffman, Debra E ^b   Dussert, Bertrand ^c   Owens, James H ^d   Jakubowski, Walter ^e   Haas, Charles N ^f   Rose, Joan B ^g  

^a Orange County Utilities   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c USFilter Wallace/Tiernan Products   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e WaltJay Consulting   (United States)

^f DREXEL UNIVERSITY   (United States)

^g MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

ClO2; Correlation; Cryptospridium parvum; HCT 8 cell line; Inactivation; Mouse infectivity; Tissue culture; UV; Zoonotic

Indexed keywords

CHLORINE DIOXIDE; HYPOCHLORITE SODIUM;

ACCURACY; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODEL; DISINFECTION; DOSE RESPONSE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OOCYST; PARASITE IDENTIFICATION; PARASITE SURVIVAL; PARASITE VIRULENCE; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE CULTURE; ULTRAVIOLET RADIATION;

ADENOCARCINOMA; ANIMALS; ANIMALS, NEWBORN; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODELS, ANIMAL; HUMANS; ILEAL NEOPLASMS; ILEOCECAL VALVE; MICE; MICE, INBRED BALB C; REGRESSION ANALYSIS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036628391     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4894(02)00100-5     Document Type: Article

References (30)

1. Armson A., Sargent K., Macdonald L.M., Flinn M.P., Thompson R.C.A., Reynoldson J.A. A comparison of the effects of two dinitroanilines against Cryptospridium parvum in in vitro and in vivo in neonatal mice and rats. FEMS Immunol. Med. Microbiol. 26:1999;109-113.
2. Arrowood M.J., Donaldson K. Improved purification methods for calf-derived Cryptospridium parvum oocysts using discontinuous sucrose and cesium chloride gradients. J. Eukaryot. Microbiol. 43(5):1996;89S.
3. Belosevic M., Guy R.A., Tagjo-Kilani R., Neumann N.F., Gyurek L.L., Liyange R.J., Millard P.J., Finch G.R. Nucleic acid stains as indicators of Cryptospridium parvum oocyst viability. Int. J. Parasitol. 27(7):1997;787-798.
4. Bukhari Z., Clancy J.L., Hargy T.M., Bolton J., Dussert B., Marshall M.M. Medium-pressure UV for oocyst inactivation. J. AWWA. 91:1999;3.
5. Campbell A.T., Robertson L.J., Smith H.V. Viability of Cryptospridium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl. Environ. Microbiol. 58(11):1992;3488-3493.
6. Clancy J.L., Bukhari Z., Hargy T.M., Bolton J., Dussert B., Marshall M.M. Using UV to inactivate Cryptospridium. J. AWWA. 92(9):2000;97-104.
7. DiGiovanni G.D., Hashemi F.H., Shaw N.J., Abrams F.A., LeChevallier M.W., Abbaszadegan M. Detection of infectious Cryptospridium parvum oocysts in surface and filter backwash water samples by immunomagnetic separation and integrated tissue culture-PCR. Appl. Environ. Microbiol. 65(8):1999;3427-3432.
8. Dupont H.L., Chappel C.L., Sterling C.R., Okhuysen P.C., Rose J.B., Jakubowski W.J. The infectivity of Cryptospridium parvum in healthy volunteers. N. England J. Med. 332:1995;855-859.
9. Ernest J.A., Blagburn B.L., Lindsay D.S., Current W.L. Infection dynamics of Cryptospridium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice Mus musculus. J. Parasitol. 72(5):1986;796-798.
10. Fayer R. Fayer R. Cryptospridium and Cryptosporidiosis. 1997;CRC Press, Boca Raton, FL.
11. Finch G.R., Daniels C.W., Black E.K., Schaffer III F.W., Belosevic M. Dose response of Cryptospridium parvum in outbred neonatal CD-1 mice. Appl. Environ. Microbiol. 59(11):1993;3661-3665.
12. Gargala G., Delaunay A., Favennec L., Brasseur P., Ballet J.J. Enzyme immunoassay detection of Cryptospridium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic Cells. Int. J. Parasitol. 29:1999;709.
13. Hijjawi N.S., Meloni B.P., Morgan U.M., Thompson R.C.A. Complete development and long-term maintenance of Cryptospridium parvum human and cattle genotypes in cell culture. Int. J. Parasitol. 31:2001;1048-1055.
14. Hoxie N.J., Davis J.P.L., Vergeront J.M., Nashold R.D., Blair K.A. cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am. J. Public Health. 87(12):1997;2032-2035.
15. Huffman D.E., Slifko T.R., Arrowood M.J., Rose J.B. Inactivation of bacteria, virus and Cryptospridium by a point-of-use device pulsed broad spectrum white light. Water Res. 34(9):2000;2491-2498.
16. Klee A.J. A computer program for the determination of the most probable number and its confidence limits. J. Microbiol. Methods. 18:1993;91-98.
17. Klee, A.J., 1995, Accessed in June2002. ICR most probable number calculator, version 1.00. Risk reduction laboratory, http://www.epa.gov/microbes . USEPA. Cincinnati, OH.
18. Korich D.G., Mead J.R., Madore M.S., Sinclair N.A., Sterling C.R. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptospridium parvum oocyst viability. Appl. Environ. Microbiol. 56(5):1990;1423-1428.
19. Okhuysen P.C., Chappell C.L., Sterling C.R., Jakubowski W., Duont H.L. Susceptibility and serologic response of healthy adults to reinfection with Cryptospridium parvum. Infect. Immun. 66(2):1998;441-443.
20. Okhuysen P.C., Chappell C.L., Crabb J.H., Sterling C.L., Dupont H.L. Virulence of three distinct Cryptospridium parvum isolates for healthy adults. J. Infect. Dis. 180:1999;1275-1281.
21. Owens, J.H., Miltner, R.J., Slifko, T.R., Rose, J.B., 1999. In vitro excystation and infectivity in mice and cell culture to assess chlorine dioxide inactivation of Cryptospridium oocysts. In: Proceedings AWWA WQTC 1999, November 1-4, 1999, Tampa, FL.
22. Peng M.M., Xiao L., Freeman A.R., Arrowood M.J., Escalente A.A., Weltman A.C., Ong C.S.L., MacKenzie W.R., Lal A.A., Beard C.B. Genetic polymorphism among Cryptospridium parvum isolates: evidence of two distinct human transmission cycles. Emerg. Infect. Dis. 3(4):1997;567-573.
23. Rennecker J.L., Marinas B.J., Owens J.H., Rice E.W. Inactivation of Cryptospridium parvum oocysts with ozone. Water Res. 33(11):1999;2481-2488.
24. Rochelle P.A., Ferguson D.M., Handojo T.J., DeLeon R., Stewart M.H., Wolfe R.L. An assay combining cell culture with reverse transcriptase PCR to determine the infectivity of waterborne Cryptospridium parvum. Appl. Environ. Microbiol. 63(5):1997;2029-2037.
25. Slifko, T.R., 2001. Development and evaluation of a quantitative cell culture assay for Cryptospridium disinfection studies. Ph.D. Dissertation. University of South Florida, St. Petersburg, FL.
26. Slifko T.R., Friedman D.E., Rose J.B., Upton S.J., Jakubowski W. Unique cultural methods used to detect viable Cryptospridium parvum oocysts in environmental samples. Water Sci. Technol. 35(11-12):1997a;363-368.
27. Slifko T.R., Friedman D.E., Rose J.B., Jakubowski W. An in vitro method for detecting infectious Cryptospridium oocysts with cell culture. Appl. Environ. Micriobiol. 63(9):1997b;3669-3675.
28. Slifko T.R., Friedman D.E., Rose J.B. A most probable number assay for the enumeration of infectious Cryptospridium parvum oocysts. Appl. Environ. Microbiol. 65(9):1999;3936-3941.
29. Eaton A.D., Clesceri L.S., Greenberg A.E. Standard Methods for the Examination of Water and Wastewater. 1995;United Book Press, Inc. Baltimore, MD.
30. Woods K.M., Nesterenko M.V., Upton S.J. Efficacy of 101 antimicrobials and other agents on the development of Cryptospridium parvum in vitro. Ann. Trop. Med. Parasitol. 90(6):1996;603-615.